prednisone has been researched along with Disease Models, Animal in 99 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here we generated a single-cell transcriptional immune cell atlas based on prednisone-treated or untreated experimental autoimmune uveitis (EAU) mice." | 8.02 | Prednisone Reprograms the Transcriptional Immune Cell Landscape in CNS Autoimmune Disease. ( Chen, B; Duan, R; Gao, Y; Li, H; Li, Z; Su, W; Wang, R; Wang, X; Xie, L; Zhu, L, 2021) |
| " However, the role of Cav-1 expression in pirfenidone-treated idiopathic pulmonary fibrosis (IPF) is unknown." | 7.85 | Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models. ( Guo, F; Song, X; Yu, W, 2017) |
| "To investigate the effects of Artemisinin on the expressions of GRalpha mRNA, GRbeta mRNA and P300/CBP protein in lupus nephritis mice." | 7.78 | [Effect of artemisinin on the expressions of GRalpha mRNA, GRbeta mRNA and P300/CBP protein in lupus nephritis mice]. ( An, P; Qiao, CL; Shi, XM; Sun, WS; Wang, Z; Wu, XL, 2012) |
| "To investigate the therapeutic effects and mechanisms of using artemisinin (Art) combined with glucocorticoid (GC) to treat lupus nephritis (LN) mice." | 7.77 | Effect of artemisinin combined with glucocorticoid on the expressions of glucocorticoid receptor α mRNA, glucocorticoid receptor β mRNA and P300/CBP protein in lupus nephritis mice. ( An, P; Qiao, CL; Shi, XM; Sun, WS; Wang, Z; Wu, XL; Zhang, WG, 2011) |
| " The efficacy of immunosuppressive doses of oral prednisone to inhibit in-stent neointimal proliferation was compared with BMS and with a commercially available paclitaxel-eluting stent (Taxus) in a rabbit model of established atherosclerosis." | 7.74 | Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis. ( Acampado, E; Crimins, J; Ferrero, V; Finn, AV; Joner, M; Kolodgie, FD; Nakazawa, G; Ribichini, F; Vassanelli, C; Virmani, R, 2007) |
| "Prednisone eliminated postoperative AFL, affected all EP parameters studied, and attenuated the inflammatory response associated with pericarditis." | 7.74 | Prednisone prevents inducible atrial flutter in the canine sterile pericarditis model. ( Goldstein, RN; Khrestian, C; Ryu, K; van Wagoner, DR; Waldo, AL, 2008) |
| "To evaluate the effect of Concanavalin A (Con A) on cataract formation in New Zealand Albino rabbits." | 7.68 | Concanavalin A-induced posterior subcapsular cataract: a new model of cataractogenesis. ( Cunanan, C; Gruber, L; Gwon, A; Mantras, C, 1993) |
| "The author presents evidence from published papers of research done by numerous investigators that Multiple, Sclerosis (MS) is an autoimmune disease, that the target tissue is the myelin sheath which covers the nerve fibers in the brain and spinal cord, that Myelin Basic Protein (MBP) is the antigen or one of the antigens involved, that the autoimmune reaction is effected by sensitized lymphocytes together with a specific antibody, that Experimental Allergic Encephalomyelitis (EAE) produced in animals can be used as a model for MS, and that the autoimmune reaction in MS can possibly be suppressed by the use of MBP given by an intravenous procedure together with an immunosuppressive drug and a corticosteroid." | 7.67 | Suppression of the immune reaction in multiple sclerosis might be achieved by intravenous injections of myelin basic protein, concomitant with the administration of an immunosuppressant and a corticosteroid. ( Eidinoff, H, 1988) |
| "The author presents evidence from published papers of research done by numerous investigators that Multiple Sclerosis (MS) is an autoimmune disease, that the target tissue is the myelin sheath which covers the nerve fibers in the brain and spinal cord, that Myelin Basic Protein (MBP) is the antigen or one of the antigens involved, that the autoimmune reaction is effected by sensitized lymphocytes together with a specific antibody, that Experimental Allergic Encephalomyelitis (EAE) produced in animals can be used as a model for MS, and that the autoimmune reaction in MS can possibly be suppressed by the use of MBP given by an intravenous procedure together with an immunosuppressive drug and a corticosteroid." | 7.67 | Suppression of the immune reaction in multiple sclerosis might be achieved by intravenous injections of myelin basic protein, concomitant with the administration of an immunosuppressant and a corticosteroid. ( Eidinoff, H, 1988) |
| "Diarrhea is the gastrointestinal disease most frequently encountered in captive rhesus macaques." | 5.35 | Effects of the macrolide drug tylosin on chronic diarrhea in rhesus macaques (Macaca mulatta). ( Blackwood, RS; Christe, KL; Lerche, NW; Spinner, A; Tarara, RP, 2008) |
| " Here we generated a single-cell transcriptional immune cell atlas based on prednisone-treated or untreated experimental autoimmune uveitis (EAU) mice." | 4.02 | Prednisone Reprograms the Transcriptional Immune Cell Landscape in CNS Autoimmune Disease. ( Chen, B; Duan, R; Gao, Y; Li, H; Li, Z; Su, W; Wang, R; Wang, X; Xie, L; Zhu, L, 2021) |
| "Combination therapy with mycophenolate mofetil, tacrolimus and steroids are effective in achieving complete remission in lupus nephritis (LN)." | 4.02 | Novel Effects of Combination Therapy Through Inhibition of Caspase-1/Gasdermin D Induced-Pyroptosis in Lupus Nephritis. ( Cao, H; He, Y; Jiang, S; Ke, Y; Liang, J; Lin, J; Liu, J; Sun, Y, 2021) |
| " Numerous clinical interventions, including those used to treat multiple sclerosis (MS), have confirmed prednisone (PDN) as a powerful anti-inflammatory drug that reduces the inflammatory response and promotes tissue repair in multiple inflammation sites." | 3.88 | Prednisone alleviates demyelination through regulation of the NLRP3 inflammasome in a C57BL/6 mouse model of cuprizone-induced demyelination. ( Cao, T; Chen, N; Fan, H; Jiang, Z; Lu, G; Wu, M; Yao, R; Yu, H; Zhang, Y, 2018) |
| "A recent clinical study showed that combination therapy consisting of mycophenolate mofetil, tacrolimus and steroids was shown to be more effective in achieving complete remission in patients with severe forms of lupus nephritis than conventional therapy consisting of intravenous cyclophosphamide and steroids." | 3.88 | Transcriptomic analysis uncovers novel synergistic mechanisms in combination therapy for lupus nephritis. ( Cai, M; Chuang, PY; Fu, J; He, JC; Lee, K; Liu, Z; Ma'ayan, A; Wang, Z; Wei, C; Zhang, M; Zhang, W; Zhou, M, 2018) |
| " However, the role of Cav-1 expression in pirfenidone-treated idiopathic pulmonary fibrosis (IPF) is unknown." | 3.85 | Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models. ( Guo, F; Song, X; Yu, W, 2017) |
| " acidophilus and prednisone acetate) protected against colitis-induced weight loss (P < 0." | 3.79 | Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis. ( Chen, LL; Li, FJ; Lian, GH; Lu, FG; Zou, YY, 2013) |
| "To investigate the effects of Artemisinin on the expressions of GRalpha mRNA, GRbeta mRNA and P300/CBP protein in lupus nephritis mice." | 3.78 | [Effect of artemisinin on the expressions of GRalpha mRNA, GRbeta mRNA and P300/CBP protein in lupus nephritis mice]. ( An, P; Qiao, CL; Shi, XM; Sun, WS; Wang, Z; Wu, XL, 2012) |
| "To investigate the therapeutic effects and mechanisms of using artemisinin (Art) combined with glucocorticoid (GC) to treat lupus nephritis (LN) mice." | 3.77 | Effect of artemisinin combined with glucocorticoid on the expressions of glucocorticoid receptor α mRNA, glucocorticoid receptor β mRNA and P300/CBP protein in lupus nephritis mice. ( An, P; Qiao, CL; Shi, XM; Sun, WS; Wang, Z; Wu, XL; Zhang, WG, 2011) |
| " The efficacy of immunosuppressive doses of oral prednisone to inhibit in-stent neointimal proliferation was compared with BMS and with a commercially available paclitaxel-eluting stent (Taxus) in a rabbit model of established atherosclerosis." | 3.74 | Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis. ( Acampado, E; Crimins, J; Ferrero, V; Finn, AV; Joner, M; Kolodgie, FD; Nakazawa, G; Ribichini, F; Vassanelli, C; Virmani, R, 2007) |
| "Prednisone eliminated postoperative AFL, affected all EP parameters studied, and attenuated the inflammatory response associated with pericarditis." | 3.74 | Prednisone prevents inducible atrial flutter in the canine sterile pericarditis model. ( Goldstein, RN; Khrestian, C; Ryu, K; van Wagoner, DR; Waldo, AL, 2008) |
| "To evaluate the effect of Concanavalin A (Con A) on cataract formation in New Zealand Albino rabbits." | 3.68 | Concanavalin A-induced posterior subcapsular cataract: a new model of cataractogenesis. ( Cunanan, C; Gruber, L; Gwon, A; Mantras, C, 1993) |
| "The author presents evidence from published papers of research done by numerous investigators that Multiple, Sclerosis (MS) is an autoimmune disease, that the target tissue is the myelin sheath which covers the nerve fibers in the brain and spinal cord, that Myelin Basic Protein (MBP) is the antigen or one of the antigens involved, that the autoimmune reaction is effected by sensitized lymphocytes together with a specific antibody, that Experimental Allergic Encephalomyelitis (EAE) produced in animals can be used as a model for MS, and that the autoimmune reaction in MS can possibly be suppressed by the use of MBP given by an intravenous procedure together with an immunosuppressive drug and a corticosteroid." | 3.67 | Suppression of the immune reaction in multiple sclerosis might be achieved by intravenous injections of myelin basic protein, concomitant with the administration of an immunosuppressant and a corticosteroid. ( Eidinoff, H, 1988) |
| "The author presents evidence from published papers of research done by numerous investigators that Multiple Sclerosis (MS) is an autoimmune disease, that the target tissue is the myelin sheath which covers the nerve fibers in the brain and spinal cord, that Myelin Basic Protein (MBP) is the antigen or one of the antigens involved, that the autoimmune reaction is effected by sensitized lymphocytes together with a specific antibody, that Experimental Allergic Encephalomyelitis (EAE) produced in animals can be used as a model for MS, and that the autoimmune reaction in MS can possibly be suppressed by the use of MBP given by an intravenous procedure together with an immunosuppressive drug and a corticosteroid." | 3.67 | Suppression of the immune reaction in multiple sclerosis might be achieved by intravenous injections of myelin basic protein, concomitant with the administration of an immunosuppressant and a corticosteroid. ( Eidinoff, H, 1988) |
| "The pathogenesis of minimal change disease (MCD), considered to be the simplest form of nephrotic syndrome, has been one of the major unsolved mysteries in kidney disease." | 2.48 | New insights into human minimal change disease: lessons from animal models. ( Chugh, SS; Clement, LC; Macé, C, 2012) |
| "Asthma is characterized by airway remodeling." | 1.62 | Glucocorticoid induced transcript 1 represses airway remodeling of asthmatic mouse via inhibiting IL-13/periostin/TGF-β1 signaling. ( Kuang, J; Wang, W; Xun, Q; Yang, Q; Zhu, G, 2021) |
| "Neuropsychiatric systemic lupus erythematosus (NPSLE) is a common cause of disability in systemic lupus erythematosus (SLE)." | 1.56 | Analysis of brain metabolites by gas chromatography-mass spectrometry reveals the risk-benefit concerns of prednisone in MRL/lpr lupus mice. ( Li, S; Lu, F; Lu, H; Wang, S; Wen, C; Wu, D; Xie, M; Xie, Z; Xu, ZH; Zhou, J, 2020) |
| " Intermittent steroid dosing has been proposed in Duchenne Muscular Dystrophy patients to mitigate the side effects seen with daily steroid intake." | 1.51 | Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming. ( Barish, GD; Bass, J; Demonbreun, AR; Haldar, SM; Jiang, Z; Kuntz, NL; McNally, EM; Peek, CB; Quattrocelli, M; Zelikovich, AS, 2019) |
| "Corticosteroids are highly prescribed and effective anti-inflammatory drugs but the burden of side effects with chronic use significantly detracts from patient quality of life, particularly in children." | 1.48 | Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone. ( Damsker, JM; Fiorillo, AA; Heier, CR; Hoffman, EP; Nagaraju, K; Tully, CB, 2018) |
| "Prednisone was the positive control in both studies." | 1.42 | Chronic Dosing with Membrane Sealant Poloxamer 188 NF Improves Respiratory Dysfunction in Dystrophic Mdx and Mdx/Utrophin-/- Mice. ( Kernodle, S; Markham, BE; Nemzek, J; Sigler, R; Wilkinson, JE, 2015) |
| "The prednisone-mediated increase in α7 integrin was associated with increased laminin-α2 in prednisone-treated dystrophin-deficient muscle." | 1.39 | Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy. ( Burkin, DJ; Kornegay, JN; Sarathy, A; Wuebbles, RD, 2013) |
| "Prednisone treatment significantly normalized the intensities of peaks 9069 and 15005 (which correspond to cortexin-1 and interleukin-17A, respectively, according to Swiss Prot database) by increasing the expression of 9069 but reducing expression of 15005." | 1.39 | Proteomic analysis indicates altered expression of plasma proteins in a rat nephropathy model. ( Ai, S; Chen, R; Lin, Q; Zheng, J, 2013) |
| "To determine the genetic susceptibility of rats to develop GC-induced femoral head ON, we evaluated 5 different inbred strains of rats (Spontaneous Hypertensive Rat, Wistar Kyoto, Wistar Furth, SASCO Fisher and Lewis)." | 1.37 | A rat model of early stage osteonecrosis induced by glucocorticoids. ( Chow, TY; Cournoyer, D; Harvey, EJ; Kerachian, MA; Nahal, A; Séguin, C, 2011) |
| "Arginine butyrate treatment improved grip strength and decreased fibrosis in the gastrocnemius muscle, but did not produce significant improvement in muscle and cardiac histology, heart function, behavioral measurements, or serum creatine kinase levels." | 1.36 | Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy. ( Becker, M; Bossi, L; Cha, HJ; de la Porte, S; Escolar, DM; Farajian, V; Francia, D; Gernapudi, R; Gordish-Dressman, H; Guerron, AD; Hoffman, EP; Nagaraju, K; Pandey, GS; Partridge, T; Pistilli, E; Rawat, R; Sali, A; Spurney, CF; Zerr, P, 2010) |
| "Diarrhea is the gastrointestinal disease most frequently encountered in captive rhesus macaques." | 1.35 | Effects of the macrolide drug tylosin on chronic diarrhea in rhesus macaques (Macaca mulatta). ( Blackwood, RS; Christe, KL; Lerche, NW; Spinner, A; Tarara, RP, 2008) |
| "Duchenne muscular dystrophy is a degenerative muscular disease caused by mutations in the dystrophin gene." | 1.32 | Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans. ( Carre-Pierrat, M; Gaud, A; Ségalat, L; Simon, JM; Wermuth, CG; Witzel, T, 2004) |
| "The aim of the study was to evaluate the effects of D-penicillamine (cuprenil), encorton and both drugs in combination on fibrotic processes in the rat liver damaged by chronic use of CCl4." | 1.28 | [Effects of D-penicillamine and encorton on the fibrotic processes in experimental liver cirrhosis in rats]. ( Czarnecki, J; Piecińska, T; Rubaj, B; Rubaj, M, 1990) |
| "Thalidomide treatment was successful in the majority of animals (16 of 18)." | 1.28 | Therapy of chronic graft-v-host disease in a rat model. ( Friedman, KJ; Hess, AD; Santos, GW; Vogelsang, GB, 1989) |
| "Prednisone may also suppress cartilage breakdown by either acting at the level of the synthesis or by acting on the release/action of the stimulating factors." | 1.27 | Role of synovial membrane inflammation in cartilage matrix breakdown in the Pond-Nuki dog model of osteoarthritis. ( Ghandur-Mnaymneh, L; Howell, DS; Martel-Pelletier, J; Pelletier, JP; Woessner, JF, 1985) |
| "In 50 to 60 percent of patients with systemic lupus erythematosus (SLE), a band of immunoglobulins beneath the epidermis of visibly normal skin." | 1.25 | The significance of cutaneous immunoglobulin deposits in lupus erythematosus and NZB/NZW F1 hybrid mice. ( Gilliam, JN, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 30 (30.30) | 18.7374 |
| 1990's | 6 (6.06) | 18.2507 |
| 2000's | 15 (15.15) | 29.6817 |
| 2010's | 38 (38.38) | 24.3611 |
| 2020's | 10 (10.10) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Li, H | 2 |
| Gao, Y | 1 |
| Xie, L | 2 |
| Wang, R | 1 |
| Duan, R | 1 |
| Li, Z | 1 |
| Chen, B | 1 |
| Zhu, L | 1 |
| Wang, X | 6 |
| Su, W | 1 |
| Wang, M | 1 |
| Zhu, Z | 1 |
| Lin, X | 1 |
| Wen, C | 3 |
| Bao, J | 1 |
| He, Z | 1 |
| Kaviani, A | 1 |
| Khansari Nejad, N | 1 |
| Akour, A | 1 |
| AlMuhaissen, SA | 1 |
| Nusair, MB | 1 |
| Al-Tammemi, AB | 1 |
| Mahmoud, NN | 1 |
| Jalouqa, S | 1 |
| Alrawashdeh, MN | 1 |
| Shanahan, JP | 1 |
| Moore, CM | 1 |
| Kampf, JW | 1 |
| Szymczak, NK | 1 |
| Guo, J | 1 |
| Wang, H | 4 |
| Luo, Y | 1 |
| An, H | 1 |
| Zhang, Z | 2 |
| Liu, G | 2 |
| Li, J | 1 |
| Metcalfe, GD | 1 |
| Smith, TW | 1 |
| Hippler, M | 1 |
| Ayala Izurieta, JE | 1 |
| Márquez, CO | 1 |
| García, VJ | 1 |
| Jara Santillán, CA | 1 |
| Sisti, JM | 1 |
| Pasqualotto, N | 1 |
| Van Wittenberghe, S | 1 |
| Delegido, J | 1 |
| Kubo, Y | 1 |
| Kitagawa, Y | 1 |
| Miyazaki, T | 1 |
| Sohda, M | 1 |
| Yamaji, T | 1 |
| Sakai, M | 1 |
| Saeki, H | 1 |
| Nemoto, K | 1 |
| Oyama, T | 2 |
| Muto, M | 1 |
| Takeuchi, H | 1 |
| Toh, Y | 1 |
| Matsubara, H | 1 |
| Mano, M | 1 |
| Kono, K | 1 |
| Kato, K | 1 |
| Yoshida, M | 1 |
| Kawakubo, H | 1 |
| Booka, E | 1 |
| Yamatsuji, T | 1 |
| Kato, H | 1 |
| Ito, Y | 1 |
| Ishikawa, H | 1 |
| Ishihara, R | 1 |
| Tsushima, T | 1 |
| Kawachi, H | 1 |
| Kojima, T | 1 |
| Kuribayashi, S | 1 |
| Makino, T | 1 |
| Matsuda, S | 1 |
| Doki, Y | 1 |
| Ma, P | 1 |
| Tang, X | 1 |
| Zhang, L | 2 |
| Wang, W | 2 |
| Zhang, X | 1 |
| Wang, S | 4 |
| Zhou, N | 1 |
| Dodd, J | 1 |
| Jordan, R | 1 |
| Makhlina, M | 1 |
| Pesco Koplowitz, L | 1 |
| Koplowitz, B | 1 |
| Barnett, K | 1 |
| Yang, WH | 1 |
| Spana, C | 1 |
| Buchanan, SW | 1 |
| Mafa-Attoye, T | 1 |
| Dunfield, K | 1 |
| Thevathasan, NV | 1 |
| Isaac, ME | 1 |
| Wu, X | 2 |
| Huang, JW | 1 |
| Su, BK | 1 |
| Yuan, L | 1 |
| Zheng, WQ | 1 |
| Zhang, H | 2 |
| Zheng, YX | 1 |
| Zhu, W | 1 |
| Chou, PT | 1 |
| Manso, AP | 1 |
| De Morais, DC | 1 |
| Yamamoto, K | 1 |
| Owen, G | 1 |
| de Carvalho, RM | 1 |
| Palma-Dibb, RG | 1 |
| Brown, JC | 1 |
| Yang, S | 1 |
| Mire, EF | 1 |
| Miele, L | 1 |
| Ochoa, A | 1 |
| Zabaleta, J | 1 |
| Katzmarzyk, PT | 1 |
| Moi, CT | 1 |
| Bhowmick, S | 1 |
| Qureshi, M | 1 |
| Wang, K | 3 |
| Feng, B | 1 |
| Yang, Y | 1 |
| Chen, Y | 1 |
| Wang, Y | 2 |
| Yang, L | 1 |
| Jiang, K | 1 |
| James, TD | 1 |
| Chaturvedi, V | 1 |
| Postiglione, WM | 1 |
| Chakraborty, RD | 1 |
| Yu, B | 1 |
| Tabiś, W | 1 |
| Hameed, S | 1 |
| Biniskos, N | 1 |
| Jacobson, A | 1 |
| Zhou, H | 1 |
| Greven, M | 1 |
| Ferry, VE | 1 |
| Leighton, C | 1 |
| Wu, F | 1 |
| Lei, H | 1 |
| Chen, G | 1 |
| Chen, C | 1 |
| Song, Y | 1 |
| Cao, Z | 1 |
| Zhang, C | 2 |
| Zhou, J | 3 |
| Lu, Y | 2 |
| Pappone, C | 1 |
| Santinelli, V | 1 |
| Mecarocci, V | 1 |
| Tondi, L | 1 |
| Ciconte, G | 1 |
| Manguso, F | 1 |
| Sturla, F | 1 |
| Vicedomini, G | 1 |
| Micaglio, E | 1 |
| Anastasia, L | 1 |
| Pica, S | 1 |
| Camporeale, A | 1 |
| Lombardi, M | 1 |
| Shieh, PB | 1 |
| Elfring, G | 1 |
| Trifillis, P | 1 |
| Santos, C | 1 |
| Peltz, SW | 1 |
| Parsons, JA | 1 |
| Apkon, S | 1 |
| Darras, BT | 1 |
| Campbell, C | 1 |
| McDonald, CM | 1 |
| Galaviz, KI | 1 |
| Shah, NS | 1 |
| Gutierrez, M | 1 |
| Collins, LF | 1 |
| Lahiri, CD | 1 |
| Moran, CA | 1 |
| Szabo, B | 1 |
| Sumitani, J | 1 |
| Rhodes, J | 1 |
| Marconi, VC | 1 |
| Nguyen, ML | 1 |
| Cantos, VD | 1 |
| Armstrong, WS | 1 |
| Colasanti, JA | 1 |
| Zareie, F | 1 |
| Ghalebandi, S | 1 |
| Askari, K | 1 |
| Mousavi, Z | 1 |
| Haghparast, A | 1 |
| Gong, K | 1 |
| Guo, G | 1 |
| Beckley, NA | 1 |
| Yang, X | 1 |
| Zhang, Y | 2 |
| Gerber, DE | 1 |
| Minna, JD | 1 |
| Burma, S | 1 |
| Zhao, D | 1 |
| Akbay, EA | 1 |
| Habib, AA | 1 |
| Cao, H | 2 |
| Liang, J | 1 |
| Liu, J | 1 |
| He, Y | 1 |
| Ke, Y | 1 |
| Sun, Y | 1 |
| Jiang, S | 1 |
| Lin, J | 1 |
| Lu, F | 2 |
| Li, S | 2 |
| Xie, M | 2 |
| Lu, H | 2 |
| Xie, Z | 1 |
| Wu, D | 1 |
| Xu, ZH | 1 |
| Quattrocelli, M | 1 |
| Zelikovich, AS | 1 |
| Jiang, Z | 2 |
| Peek, CB | 1 |
| Demonbreun, AR | 1 |
| Kuntz, NL | 1 |
| Barish, GD | 1 |
| Haldar, SM | 1 |
| Bass, J | 1 |
| McNally, EM | 1 |
| Tomazoni, SS | 1 |
| Casalechi, HL | 1 |
| Ferreira, CSB | 1 |
| Serra, AJ | 1 |
| Dellê, H | 1 |
| Brito, RBO | 1 |
| de Melo, BL | 1 |
| Vanin, AA | 1 |
| Ribeiro, NF | 1 |
| Pereira, AL | 1 |
| Monteiro, KKDS | 1 |
| Marcos, RL | 1 |
| de Carvalho, PTC | 1 |
| Frigo, L | 1 |
| Leal-Junior, ECP | 1 |
| Xun, Q | 1 |
| Kuang, J | 1 |
| Yang, Q | 1 |
| Zhu, G | 1 |
| Zheng, C | 1 |
| Xu, X | 1 |
| Zhao, Y | 1 |
| Liu, Z | 3 |
| Zhao, X | 1 |
| Qi, X | 1 |
| Wang, C | 1 |
| Zhou, Z | 1 |
| Wu, P | 1 |
| Li, L | 1 |
| Lu, S | 1 |
| Wang, Z | 4 |
| Yu, H | 1 |
| Wu, M | 1 |
| Lu, G | 1 |
| Cao, T | 1 |
| Chen, N | 1 |
| Fan, H | 1 |
| Yao, R | 1 |
| Fu, J | 1 |
| Lee, K | 1 |
| Wei, C | 1 |
| Zhang, M | 2 |
| Zhou, M | 1 |
| Cai, M | 1 |
| Zhang, W | 1 |
| Chuang, PY | 1 |
| Ma'ayan, A | 1 |
| He, JC | 1 |
| Zhong, X | 1 |
| Liu, D | 1 |
| Liu, L | 1 |
| Xia, Z | 1 |
| Fiorillo, AA | 1 |
| Tully, CB | 1 |
| Damsker, JM | 1 |
| Nagaraju, K | 2 |
| Hoffman, EP | 2 |
| Heier, CR | 1 |
| Zhang, J | 1 |
| Li, Q | 1 |
| Shao, Q | 1 |
| Song, J | 1 |
| Zhou, B | 1 |
| Shu, P | 1 |
| Liu, Y | 2 |
| Jia, Z | 1 |
| Akhter, MP | 2 |
| Gao, X | 2 |
| Zhao, G | 2 |
| Wei, X | 2 |
| Zhou, Y | 2 |
| Hartman, CW | 1 |
| Fehringer, EV | 1 |
| Cui, L | 3 |
| Wang, D | 2 |
| Liu, YZ | 1 |
| Wang, XY | 1 |
| Wang, XB | 1 |
| Wu, HJ | 1 |
| Chen, H | 1 |
| Feng, T | 1 |
| Guo, D | 1 |
| Chen, L | 1 |
| DeWeerdt, S | 1 |
| Chen, R | 2 |
| Zhang, Q | 1 |
| Chen, S | 1 |
| Tang, H | 1 |
| Huang, P | 1 |
| Wei, S | 1 |
| Liang, Z | 1 |
| Chen, X | 1 |
| Tao, A | 1 |
| Yao, L | 1 |
| Zahn, NM | 1 |
| Huber, AT | 1 |
| Mikulsky, BN | 1 |
| Stepanski, ME | 1 |
| Kehoe, AS | 1 |
| Li, G | 2 |
| Schussman, M | 1 |
| Rashid Roni, MS | 1 |
| Kodali, R | 1 |
| Cook, JM | 1 |
| Stafford, DC | 1 |
| Steeber, DA | 1 |
| Arnold, LA | 1 |
| Zu, Y | 1 |
| Yu, J | 1 |
| Ruan, Y | 1 |
| Xu, Z | 1 |
| Wuebbles, RD | 1 |
| Sarathy, A | 1 |
| Kornegay, JN | 1 |
| Burkin, DJ | 1 |
| Chen, LL | 1 |
| Zou, YY | 1 |
| Lu, FG | 1 |
| Li, FJ | 1 |
| Lian, GH | 1 |
| Clarke, DL | 1 |
| Davis, NH | 1 |
| Majithiya, JB | 1 |
| Piper, SC | 1 |
| Lewis, A | 1 |
| Sleeman, MA | 1 |
| Corkill, DJ | 1 |
| May, RD | 1 |
| Lin, S | 1 |
| Huang, J | 1 |
| Zheng, L | 1 |
| Li, N | 1 |
| Zou, L | 1 |
| Wu, T | 1 |
| Qin, L | 1 |
| Markham, BE | 1 |
| Kernodle, S | 1 |
| Nemzek, J | 1 |
| Wilkinson, JE | 1 |
| Sigler, R | 1 |
| Chen, F | 1 |
| Ma, YL | 1 |
| Ding, H | 1 |
| Chen, BP | 1 |
| Sinha, S | 1 |
| Uchibe, K | 1 |
| Usami, Y | 1 |
| Pacifici, M | 1 |
| Iwamoto, M | 1 |
| Carli, AV | 1 |
| Harvey, EJ | 2 |
| Azeddine, B | 1 |
| Gao, C | 1 |
| Li, Y | 1 |
| Li, A | 1 |
| Sayegh, M | 1 |
| Nahal, A | 2 |
| Michel, RP | 1 |
| Henderson, JE | 1 |
| Séguin, C | 2 |
| Klanova, M | 1 |
| Soukup, T | 1 |
| Molinsky, J | 1 |
| Lateckova, L | 1 |
| Vockova, P | 1 |
| Alam, M | 1 |
| Zivny, J | 1 |
| Trneny, M | 1 |
| Klener, P | 1 |
| Karau, MJ | 1 |
| Greenwood-Quaintance, KE | 1 |
| Block, DR | 1 |
| Mandrekar, JN | 1 |
| Cunningham, SA | 1 |
| Patel, R | 1 |
| Yu, W | 1 |
| Guo, F | 1 |
| Song, X | 1 |
| Yokote, Y | 1 |
| Kimura, E | 1 |
| Kimura, M | 1 |
| Kozono, Y | 1 |
| Tankéré, F | 1 |
| Bernat, I | 1 |
| Blackwood, RS | 1 |
| Tarara, RP | 1 |
| Christe, KL | 1 |
| Spinner, A | 1 |
| Lerche, NW | 1 |
| Guerron, AD | 1 |
| Rawat, R | 1 |
| Sali, A | 1 |
| Spurney, CF | 1 |
| Pistilli, E | 1 |
| Cha, HJ | 1 |
| Pandey, GS | 1 |
| Gernapudi, R | 1 |
| Francia, D | 1 |
| Farajian, V | 1 |
| Escolar, DM | 1 |
| Bossi, L | 1 |
| Becker, M | 1 |
| Zerr, P | 1 |
| de la Porte, S | 1 |
| Gordish-Dressman, H | 1 |
| Partridge, T | 1 |
| Sharma, N | 1 |
| Moeller, CW | 1 |
| Marzo, SJ | 1 |
| Jones, KJ | 1 |
| Foecking, EM | 1 |
| Kaplan, FS | 1 |
| Pignolo, RJ | 1 |
| Shore, EM | 1 |
| Bouazzaoui, A | 1 |
| Spacenko, E | 1 |
| Mueller, G | 1 |
| Huber, E | 1 |
| Schubert, T | 1 |
| Holler, E | 1 |
| Andreesen, R | 1 |
| Hildebrandt, GC | 1 |
| Wu, XL | 2 |
| Zhang, WG | 1 |
| Shi, XM | 2 |
| An, P | 2 |
| Sun, WS | 2 |
| Qiao, CL | 2 |
| Chugh, SS | 1 |
| Clement, LC | 1 |
| Macé, C | 1 |
| Kerachian, MA | 1 |
| Cournoyer, D | 1 |
| Chow, TY | 1 |
| Keel, SB | 1 |
| Phelps, S | 1 |
| Sabo, KM | 1 |
| O'Leary, MN | 1 |
| Kirn-Safran, CB | 1 |
| Abkowitz, JL | 1 |
| Ai, S | 1 |
| Zheng, J | 1 |
| Lin, Q | 1 |
| Garber, K | 1 |
| Oskooii, AE | 1 |
| Gholizad, LM | 1 |
| Zare, S | 1 |
| Nejati, V | 1 |
| Han, JK | 1 |
| Woodson, BT | 1 |
| Gaud, A | 1 |
| Simon, JM | 1 |
| Witzel, T | 1 |
| Carre-Pierrat, M | 1 |
| Wermuth, CG | 1 |
| Ségalat, L | 1 |
| De Luca, A | 1 |
| Vossen, M | 1 |
| Majzoub, RK | 1 |
| Edelstein, J | 1 |
| Perez-Abadia, G | 1 |
| Voor, M | 1 |
| Maldonado, C | 1 |
| Tecimer, T | 1 |
| Jevans, AW | 1 |
| Zdichavsky, M | 1 |
| Frank, JM | 1 |
| Francois, C | 1 |
| Kon, M | 1 |
| Barker, JH | 1 |
| Zhang, HQ | 1 |
| Yau, YF | 1 |
| Szeto, KY | 1 |
| Chan, WT | 1 |
| Wong, J | 1 |
| Li, M | 1 |
| Gomes, AT | 1 |
| Cunha, LM | 1 |
| Bastos, CG | 1 |
| Medrado, BF | 1 |
| Assis, BC | 1 |
| Andrade, ZA | 1 |
| Xiong, M | 1 |
| Dang, X | 1 |
| Ribichini, F | 1 |
| Joner, M | 1 |
| Ferrero, V | 1 |
| Finn, AV | 1 |
| Crimins, J | 1 |
| Nakazawa, G | 1 |
| Acampado, E | 1 |
| Kolodgie, FD | 1 |
| Vassanelli, C | 1 |
| Virmani, R | 1 |
| Goldstein, RN | 1 |
| Ryu, K | 1 |
| Khrestian, C | 1 |
| van Wagoner, DR | 1 |
| Waldo, AL | 1 |
| Marcus, GM | 1 |
| Scheinman, MM | 1 |
| Aguila, B | 1 |
| Coulbault, L | 1 |
| Boulouard, M | 1 |
| Léveillé, F | 1 |
| Davis, A | 1 |
| Tóth, G | 1 |
| Borsodi, A | 1 |
| Balboni, G | 1 |
| Salvadori, S | 1 |
| Jauzac, P | 1 |
| Allouche, S | 1 |
| Abramsky, O | 1 |
| Seybold, ME | 1 |
| Harper, JS | 2 |
| Genta, RM | 2 |
| Gam, A | 1 |
| London, WT | 1 |
| Neva, FA | 2 |
| Gam, AA | 1 |
| London, WI | 1 |
| Ginzler, EM | 1 |
| Bollet, AJ | 1 |
| Friedman, EA | 1 |
| Hogenesch, H | 1 |
| Snyder, PW | 1 |
| Scott-Moncrieff, JC | 1 |
| Glickman, LT | 1 |
| Felsburg, PJ | 1 |
| Gwon, A | 1 |
| Mantras, C | 1 |
| Gruber, L | 1 |
| Cunanan, C | 1 |
| Mizuno, S | 1 |
| Mizuno-Horikawa, Y | 1 |
| Yue, BF | 1 |
| Okamoto, M | 1 |
| Kurosawa, T | 1 |
| Bohm, RP | 1 |
| Dennis, V | 1 |
| Blanchard, JL | 1 |
| Philipp, MT | 1 |
| Gerber, MA | 1 |
| Madsen, LW | 1 |
| Aalbaek, B | 1 |
| Nielsen, OL | 1 |
| Jensen, HE | 1 |
| Croft, CB | 1 |
| Zub, K | 1 |
| Borowiecki, B | 1 |
| Metheny, JA | 1 |
| DeVita, VT | 1 |
| Gilliam, JN | 1 |
| Galus, K | 1 |
| Tałałaj, M | 1 |
| Smogorzewski, M | 1 |
| Madej, K | 1 |
| Karolak, M | 1 |
| Wall, W | 1 |
| Rubaj, M | 1 |
| Czarnecki, J | 1 |
| Rubaj, B | 1 |
| Piecińska, T | 1 |
| Eidinoff, H | 2 |
| Vogelsang, GB | 1 |
| Hess, AD | 1 |
| Friedman, KJ | 1 |
| Santos, GW | 1 |
| Pelletier, JP | 1 |
| Martel-Pelletier, J | 1 |
| Ghandur-Mnaymneh, L | 1 |
| Howell, DS | 1 |
| Woessner, JF | 1 |
| Goldberg, AI | 1 |
| Glynn, JP | 1 |
| Kende, M | 1 |
| Mantel, N | 1 |
| Goldin, A | 3 |
| Burns, RP | 1 |
| Beard, ME | 1 |
| Weimar, VL | 1 |
| Squires, EL | 1 |
| Underwood, GE | 1 |
| Weed, SD | 1 |
| Schabel, FM | 2 |
| Skipper, HE | 1 |
| Trader, MW | 1 |
| Laster, WR | 1 |
| Cheeks, JB | 1 |
| Frei, E | 2 |
| Flindall, RJ | 1 |
| Leonard, BC | 1 |
| Squire, RA | 1 |
| Bush, M | 1 |
| Melby, EC | 1 |
| Neeley, LM | 1 |
| Yarbrough, B | 1 |
| Robertson, JH | 1 |
| Crozier, EH | 1 |
| Hollinger, M | 1 |
| Black, DA | 1 |
| Nowakowski, A | 1 |
| Grove, RB | 1 |
| King, LH | 1 |
| Antonovych, TT | 1 |
| Fortner, RW | 1 |
| Knieser, MR | 1 |
| Carter, CB | 1 |
| Knepshield, JH | 1 |
| Klastersky, J | 1 |
| Sandberg, JS | 1 |
| Henderson, ES | 1 |
| Newman, JW | 1 |
| Holland, JF | 1 |
| Mielens, ZE | 1 |
| Komarek, A | 1 |
| Dietrich, FM | 1 |
| Zubrod, CG | 1 |
| Halawani, A | 1 |
| Selim, MS | 1 |
| Abddallah, AA | 1 |
| D'Alena, P | 1 |
| Okumoto, M | 1 |
| Crawford, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluating the Impact of Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD)[NCT03319030] | 43 participants (Actual) | Observational | 2017-09-01 | Completed | |||
| A Phase II Open-Label, Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of Vamorolone in Boys Ages 2 to <4 Years and 7 to <18 Years With Duchenne Muscular Dystrophy (DMD)[NCT05185622] | Phase 2 | 54 participants (Anticipated) | Interventional | 2022-03-21 | Recruiting | ||
| A Phase II Pilot Trial of Vamorolone vs. Placebo for the Treatment of Becker Muscular Dystrophy[NCT05166109] | Phase 2 | 39 participants (Anticipated) | Interventional | 2022-07-07 | Recruiting | ||
| Clinical and Angiographic Outcome of Patients Treated With Bare Metal Stent (BMS) Implantation Compared With Drug Eluting Stents or BMS Plus Systemic Prednisone Therapy. A Randomized, Multicentre Study.[NCT00369356] | Phase 2/Phase 3 | 375 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for prednisone and Disease Models, Animal
| Article | Year |
|---|---|
Topics: Adult; Alcohol Drinking; Ammonia; Animals; Anti-Inflammatory Agents; Area Under Curve; B-Lymphocytes | 2021 |
[Bell's palsy: from viral aetiology to diagnostic reality].
Topics: Acyclovir; Administration, Oral; Adrenal Cortex Hormones; Animals; Anti-Inflammatory Agents; Antivir | 2009 |
New insights into human minimal change disease: lessons from animal models.
Topics: Angiopoietin-Like Protein 4; Angiopoietins; Animals; Disease Models, Animal; Glucocorticoids; Humans | 2012 |
Myasthenia gravis and acetylcholine receptor: autoimmunity and steroid effects.
Topics: Adrenal Cortex Hormones; Animals; Autoantibodies; Autoimmune Diseases; Disease Models, Animal; Human | 1980 |
Myasthenia gravis. A clinical and basic science review.
Topics: Adrenal Cortex Hormones; Adult; Animals; Autoantibodies; Child; Disease Models, Animal; Electromyogr | 1983 |
The natural history and response to therapy of lupus nephritis.
Topics: Animals; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Disease Models, Animal; Fluoresce | 1980 |
Dermatomyositis: a vocal and swallowing disease entity.
Topics: Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Deglutition Disorders; Dermatomyositis; D | 1978 |
Human models of human diseases; breast cancer and the lymphomas.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Disease Models, Animal; Drug Therapy, Combination; | 1979 |
Immunosuppressive agents in protein-losing nephritis.
Topics: Animals; Azathioprine; Cyclophosphamide; Disease Models, Animal; Glomerulonephritis; Humans; Hyperse | 1970 |
Effectiveness of adrenal corticosteroids in the management of severe bacterial infections.
Topics: Adrenal Glands; Animals; Anti-Bacterial Agents; Bacterial Infections; Betamethasone; Brain Edema; Ce | 1971 |
The chemotherapy of human and animal acute leukemia.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Azaserine; Cell Division; | 1971 |
3 trials available for prednisone and Disease Models, Animal
| Article | Year |
|---|---|
The natural history and response to therapy of lupus nephritis.
Topics: Animals; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Disease Models, Animal; Fluoresce | 1980 |
Therapy of iatrogenic subglottic stenosis: a steroid/antibiotic regimen.
Topics: Aged; Animals; Clinical Trials as Topic; Disease Models, Animal; Female; Glottis; Humans; Iatrogenic | 1979 |
The chemotherapy of human and animal acute leukemia.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Azaserine; Cell Division; | 1971 |
87 other studies available for prednisone and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Prednisone Reprograms the Transcriptional Immune Cell Landscape in CNS Autoimmune Disease.
Topics: Animals; Autoimmune Diseases; B-Lymphocytes; Disease Models, Animal; Gene Expression Profiling; Gene | 2021 |
Gut microbiota mediated the therapeutic efficacies and the side effects of prednisone in the treatment of MRL/lpr mice.
Topics: Animals; Disease Models, Animal; Gastrointestinal Microbiome; Glucocorticoids; Lupus Erythematosus, | 2021 |
Orexin receptors in the CA1 region of hippocampus modulate the stress-induced antinociceptive responses in an animal model of persistent inflammatory pain.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzoxazoles; CA1 Region, Hippocampal; Cycl | 2022 |
Comprehensive targeting of resistance to inhibition of RTK signaling pathways by using glucocorticoids.
Topics: A549 Cells; Animals; Carcinoma, Non-Small-Cell Lung; Cytokines; Disease Models, Animal; Drug Resista | 2021 |
Novel Effects of Combination Therapy Through Inhibition of Caspase-1/Gasdermin D Induced-Pyroptosis in Lupus Nephritis.
Topics: Adolescent; Adult; Aged; Animals; Calcineurin Inhibitors; Caspase 1; Caspase Inhibitors; Cells, Cult | 2021 |
Analysis of brain metabolites by gas chromatography-mass spectrometry reveals the risk-benefit concerns of prednisone in MRL/lpr lupus mice.
Topics: Animals; Brain; Disease Models, Animal; Female; Gas Chromatography-Mass Spectrometry; Glucocorticoid | 2020 |
Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-metabolic reprogramming.
Topics: Anacardic Acids; Animals; Biomarkers; Child; Cross-Sectional Studies; Disease Models, Animal; Drug T | 2019 |
Can photobiomodulation therapy be an alternative to pharmacological therapies in decreasing the progression of skeletal muscle impairments of mdx mice?
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Combined Modality Therapy; Disease Models, Animal; | 2020 |
Glucocorticoid induced transcript 1 represses airway remodeling of asthmatic mouse via inhibiting IL-13/periostin/TGF-β1 signaling.
Topics: Airway Remodeling; Aluminum Hydroxide; Animals; Asthma; Cell Adhesion Molecules; Disease Models, Ani | 2021 |
Fibrinogen links podocyte injury with Toll-like receptor 4 and is associated with disease activity in FSGS patients.
Topics: Actin Cytoskeleton; Adolescent; Adult; Albuminuria; Animals; Apoptosis; Cell Line; Disease Models, A | 2018 |
Idiopathic thrombocytopenic purpura: pathogenesis and potential therapeutic approach.
Topics: Adult; Aged; Animals; Disease Models, Animal; Drugs, Chinese Herbal; Enzyme-Linked Immunosorbent Ass | 2017 |
Prednisone alleviates demyelination through regulation of the NLRP3 inflammasome in a C57BL/6 mouse model of cuprizone-induced demyelination.
Topics: Animals; Astrocytes; Corpus Callosum; Cuprizone; Cytokines; Demyelinating Diseases; Disease Models, | 2018 |
Transcriptomic analysis uncovers novel synergistic mechanisms in combination therapy for lupus nephritis.
Topics: Animals; Cytoskeleton; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Ge | 2018 |
The effects of freeze-dried Ganoderma lucidum mycelia on a recurrent oral ulceration rat model.
Topics: Animals; Biological Products; Cytokines; Disease Models, Animal; Forkhead Transcription Factors; Fre | 2017 |
Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone.
Topics: Animals; Base Sequence; Chronic Disease; Disease Models, Animal; Gene Expression Regulation; Inflamm | 2018 |
Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone.
Topics: Animals; Base Sequence; Chronic Disease; Disease Models, Animal; Gene Expression Regulation; Inflamm | 2018 |
Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone.
Topics: Animals; Base Sequence; Chronic Disease; Disease Models, Animal; Gene Expression Regulation; Inflamm | 2018 |
Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone.
Topics: Animals; Base Sequence; Chronic Disease; Disease Models, Animal; Gene Expression Regulation; Inflamm | 2018 |
Effects of panax notoginseng saponin on the pathological ultrastructure and serum IL-6 and IL-8 in pulmonary fibrosis in rabbits.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Creatine Kinas | 2018 |
Bone-targeting liposome formulation of Salvianic acid A accelerates the healing of delayed fracture Union in Mice.
Topics: Animals; Anti-Inflammatory Agents; Caffeic Acids; Cholesterol; Disease Models, Animal; Drug Compound | 2018 |
Glucocorticoid-induced delayed fracture healing and impaired bone biomechanical properties in mice.
Topics: Animals; Biomechanical Phenomena; Bone Remodeling; Bony Callus; Disease Models, Animal; Female; Femo | 2018 |
Sanggenon C Stimulates Osteoblastic Proliferation and Differentiation, Inhibits Osteoclastic Resorption, and Ameliorates Prednisone-Induced Osteoporosis in Zebrafish Model.
Topics: Alkaline Phosphatase; Animals; Benzofurans; Cell Differentiation; Cell Line; Cell Proliferation; Chr | 2018 |
How dogs are teaching researchers new tricks for treating cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Clinical Trials, Veterinar | 2018 |
IL-17F, rather than IL-17A, underlies airway inflammation in a steroid-insensitive toluene diisocyanate-induced asthma model.
Topics: Animals; Asthma; Bronchodilator Agents; Disease Models, Animal; Drug Resistance; Fluticasone; Glucoc | 2019 |
MIDD0301 - A first-in-class anti-inflammatory asthma drug targets GABA
Topics: Adjuvants, Immunologic; Administration, Oral; Animals; Anti-Inflammatory Agents; Asthma; Azepines; D | 2019 |
Limited preventive effect of prednisone on neuropsychiatric symptoms in murine systemic lupus erythematosus.
Topics: Animals; Brain; Cardiolipins; Depression; Disease Models, Animal; Female; Glucocorticoids; Lupus Vas | 2019 |
Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy.
Topics: Animals; Antigens, CD; Disease Models, Animal; Dogs; Gene Expression Regulation; Humans; Integrin al | 2013 |
Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitis.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Colitis; Colon; Dextran Sulfate; Disease Models, Ani | 2013 |
Development of a mouse model mimicking key aspects of a viral asthma exacerbation.
Topics: Animals; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; CD4-Positive T-Lymphocytes | 2014 |
Glucocorticoid-induced osteoporosis in growing rats.
Topics: Acetates; Animals; Biomarkers; Biomechanical Phenomena; Body Weight; Bone Resorption; Densitometry; | 2014 |
Chronic Dosing with Membrane Sealant Poloxamer 188 NF Improves Respiratory Dysfunction in Dystrophic Mdx and Mdx/Utrophin-/- Mice.
Topics: Animals; Anti-Inflammatory Agents; Diaphragm; Disease Models, Animal; Dose-Response Relationship, Dr | 2015 |
Effects of Tripterygium wilfordii glycosides on regulatory T cells and Th17 in an IgA nephropathy rat model.
Topics: Animals; Disease Models, Animal; Glomerulonephritis, IGA; Glycosides; Humans; Prednisone; Rats; T-Ly | 2015 |
Effectiveness and mode of action of a combination therapy for heterotopic ossification with a retinoid agonist and an anti-inflammatory agent.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Cartilage; Cell Movement; Dexamethasone; Disease Mod | 2016 |
Substrain-specific differences in bone parameters, alpha-2-macroglobulin circulating levels, and osteonecrosis incidence in a rat model.
Topics: alpha-Macroglobulins; Animals; Blood Glucose; Body Weight; Disease Models, Animal; Femur Head; Femur | 2017 |
Single-agent cytarabine is insufficient for the treatment of human mantle cell lymphoma in mouse xenograft model.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, | 2016 |
Ureaplasma urealyticum Causes Hyperammonemia in an Experimental Immunocompromised Murine Model.
Topics: Ammonia; Animals; Disease Models, Animal; Hyperammonemia; Immunocompromised Host; Immunosuppressive | 2016 |
Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models.
Topics: Acetylcysteine; Animals; Bleomycin; Blotting, Western; Caveolin 1; Cytoprotection; Disease Models, A | 2017 |
Biomechanical analysis of combined treatment of high calcium and bisphosphonate in tibia of steroid-treated growing-phase rats.
Topics: Absorptiometry, Photon; Animals; Biomechanical Phenomena; Bone Density; Bone Density Conservation Ag | 2008 |
Effects of the macrolide drug tylosin on chronic diarrhea in rhesus macaques (Macaca mulatta).
Topics: Animals; Anti-Bacterial Agents; C-Reactive Protein; Chronic Disease; Colonoscopy; Cytokines; Diarrhe | 2008 |
Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy.
Topics: Animals; Arginine; Behavior, Animal; Butyrates; Disease Models, Animal; Drug Therapy, Combination; F | 2010 |
Combinatorial treatments enhance recovery following facial nerve crush.
Topics: Animals; Combined Modality Therapy; Disease Models, Animal; Electric Stimulation Therapy; Facial Ner | 2010 |
Viewing FOP through rosi-colored glasses.
Topics: Animals; Disease Models, Animal; Female; Humans; Middle Aged; Myositis Ossificans; Prednisone; Rosig | 2010 |
Steroid treatment alters adhesion molecule and chemokine expression in experimental acute graft-vs.-host disease of the intestinal tract.
Topics: Animals; Bone Marrow Transplantation; Cell Adhesion Molecules; Chemokines; Cytokines; Disease Models | 2011 |
Effect of artemisinin combined with glucocorticoid on the expressions of glucocorticoid receptor α mRNA, glucocorticoid receptor β mRNA and P300/CBP protein in lupus nephritis mice.
Topics: Animals; Artemisinins; Base Sequence; Disease Models, Animal; DNA Primers; Electrophoresis, Agar Gel | 2011 |
A rat model of early stage osteonecrosis induced by glucocorticoids.
Topics: Animals; Apoptosis; Disease Models, Animal; Drug Implants; Female; Femur Head Necrosis; Genetic Pred | 2011 |
Establishing Rps6 hemizygous mice as a model for studying how ribosomal protein haploinsufficiency impairs erythropoiesis.
Topics: Agranulocytosis; Alleles; Anemia, Diamond-Blackfan; Anemia, Macrocytic; Animals; Chromosome Deletion | 2012 |
Proteomic analysis indicates altered expression of plasma proteins in a rat nephropathy model.
Topics: Animals; Biomarkers; Blood Proteins; Databases, Protein; Disease Models, Animal; Doxorubicin; Glucoc | 2013 |
Biochemistry: A radical treatment.
Topics: Animals; Antioxidants; Clinical Trials as Topic; Disease Models, Animal; Free Radicals; Humans; Isot | 2012 |
[Effect of artemisinin on the expressions of GRalpha mRNA, GRbeta mRNA and P300/CBP protein in lupus nephritis mice].
Topics: Animals; Artemisia annua; Artemisinins; Disease Models, Animal; Female; Leukocytes, Mononuclear; Lup | 2012 |
A comparison of effects of ABVD and ChlVPP chemotherapeutic protocols for Hodgkin's disease on rats' epididiymal and testicular tissues.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Dacarbazine; Disea | 2010 |
Effects of prednisone and ibuprofen on radio frequency volume tissue reduction in a rabbit model.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Data Interpretation, Sta | 2002 |
Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans.
Topics: Animals; Anti-Inflammatory Agents; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Disease | 2004 |
Prednisone in dystrophin-deficient Caernorabditis elegans.
Topics: Animals; Anti-Inflammatory Agents; Caenorhabditis elegans; Disease Models, Animal; Dystrophin; Muscu | 2004 |
Bone quality in swine composite tissue allografts: effects of combination immunotherapy.
Topics: Animals; Bone Density; Disease Models, Animal; Drug Therapy, Combination; Forelimb; Glucocorticoids; | 2005 |
Therapeutic effect of Chinese medicine formula DSQRL on experimental pulmonary fibrosis.
Topics: Animals; Bronchoalveolar Lavage Fluid; Carbon Tetrachloride; Collagen; Disease Models, Animal; Drugs | 2007 |
Capillaria hepatica in rats: focal parasitic hepatic lesions and septal fibrosis run independent courses.
Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Capillaria; Chronic Disease; Disease Models, Anim | 2006 |
[An experimental study on osteocyte apoptosis in steroid-induced early osteonecrosis of femoral head].
Topics: Animals; Apoptosis; Disease Models, Animal; Female; Femur Head; Femur Head Necrosis; In Situ Nick-En | 2007 |
Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Aorta; Atherosclerosis; Cell Proliferation; | 2007 |
Prednisone prevents inducible atrial flutter in the canine sterile pericarditis model.
Topics: Animals; Anti-Inflammatory Agents; Atrial Flutter; Disease Models, Animal; Dogs; Dose-Response Relat | 2008 |
Preventing atrial flutter by preventing inflammation.
Topics: Animals; Anti-Inflammatory Agents; Atrial Flutter; Disease Models, Animal; Dogs; Dose-Response Relat | 2008 |
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance.
Topics: Animals; Antidepressive Agents; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bind | 2007 |
Experimental disseminated strongyloidiasis in Erythrocebus patas. I. Pathology.
Topics: Animals; Basophils; Cercopithecidae; Disease Models, Animal; Eosinophilia; Erythrocebus patas; Immun | 1984 |
Experimental disseminated strongyloidiasis in Erythrocebus patas. II. Immunology.
Topics: Animals; Cercopithecidae; Disease Models, Animal; Erythrocebus patas; Immunoglobulin E; Immunoglobul | 1984 |
Interleukin-6 activity in dogs with juvenile polyarteritis syndrome: effect of corticosteroids.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Dog Diseases; Dogs; Fever; Imm | 1995 |
Concanavalin A-induced posterior subcapsular cataract: a new model of cataractogenesis.
Topics: Administration, Topical; Animals; Anterior Chamber; Cataract; Concanavalin A; Disease Models, Animal | 1993 |
Nephrotic mice (ICGN strain): a model of diffuse mesangial sclerosis in infantile nephrotic syndrome.
Topics: Albuminuria; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Glomerular Mesangium; Immuno | 1999 |
Clinical outcome of a protocol to produce immunosuppression in rhesus monkeys (Macaca mulatta): application to infectious disease and gene therapy studies.
Topics: Animals; Cyclophosphamide; Disease Models, Animal; Dose-Response Relationship, Drug; Genetic Therapy | 1999 |
Aerogenous infection of microbiologically defined minipigs with Streptococcus suis serotype 2. A new model.
Topics: Animals; Antigens, Bacterial; Bacteremia; Disease Models, Animal; Female; Humans; Immunohistochemist | 2001 |
The significance of cutaneous immunoglobulin deposits in lupus erythematosus and NZB/NZW F1 hybrid mice.
Topics: Animals; Antibodies; Autoantigens; Autoimmune Diseases; Blood Proteins; Cell Nucleus; Complement Sys | 1975 |
[Comparison of the effects of sodium fluoride and calcidiol on the remodeling of the endosteal surface of the rib cortex in dogs after administration of prednisone].
Topics: Animals; Bone Remodeling; Calcifediol; Disease Models, Animal; Dogs; Drug Synergism; Osteoporosis; P | 1992 |
[Effects of D-penicillamine and encorton on the fibrotic processes in experimental liver cirrhosis in rats].
Topics: Animals; Carbon Tetrachloride Poisoning; Collagen; Disease Models, Animal; Dose-Response Relationshi | 1990 |
Suppression of the immune reaction in multiple sclerosis might be achieved by intravenous injections of myelin basic protein, concomitant with the administration of an immunosuppressant and a corticosteroid.
Topics: Autoimmune Diseases; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Humans; Im | 1988 |
Suppression of the immune reaction in multiple sclerosis might be achieved by intravenous injections of myelin basic protein, concomitant with the administration of an immunosuppressant and a corticosteroid.
Topics: Animals; Autoimmune Diseases; Azathioprine; Disease Models, Animal; Drug Therapy, Combination; Encep | 1988 |
Therapy of chronic graft-v-host disease in a rat model.
Topics: Animals; Azathioprine; Cyclosporins; Disease Models, Animal; Drug Synergism; Graft vs Host Disease; | 1989 |
Role of synovial membrane inflammation in cartilage matrix breakdown in the Pond-Nuki dog model of osteoarthritis.
Topics: Animals; Cartilage, Articular; Disease Models, Animal; DNA; Dogs; Microbial Collagenase; Osteoarthri | 1985 |
A two-stage therapeutic design in the spontaneous AKR lymphoma system.
Topics: Amides; Animals; Antineoplastic Agents; Azacitidine; Cyclic P-Oxides; Cyclophosphamide; Cytarabine; | 1972 |
Modification of 1-tyrosine-induced keratopathy by adrenal corticosteroids.
Topics: Animals; Betamethasone; Corneal Opacity; Dexamethasone; Dietary Proteins; Disease Models, Animal; Fe | 1974 |
Recurrent cutaneous herpes simplex in hairless mice.
Topics: Animals; Culture Techniques; Cytopathogenic Effect, Viral; Disease Models, Animal; Hair; Herpes Simp | 1974 |
Combination chemotherapy for spontaneous AKR lymphoma.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytara | 1974 |
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytara | 1974 |
The effect of corticosteroids on the retinal cryoadhesion.
Topics: Adhesiveness; Animals; Biomedical Engineering; Conjunctiva; Cryosurgery; Disease Models, Animal; Inf | 1973 |
Clinical and pathologic study of canine lymphoma: clinical staging, cell classification, and therapy.
Topics: Animals; Antineoplastic Agents; Bacterial Infections; Cyclophosphamide; Disease Models, Animal; Dog | 1973 |
Corticosteroid therapy in Felty's syndrome and its effect on hypersplenic rats.
Topics: Aged; Anemia; Animals; Body Weight; Chromium Radioisotopes; Disease Models, Animal; Felty Syndrome; | 1974 |
Goodpasture's syndrome: recovery from severe pulmonary hemorrhage after bilateral nephrectomy.
Topics: Adult; Anti-Glomerular Basement Membrane Disease; Autoantibodies; Azathioprine; Complement System Pr | 1971 |
Response of "acute phase" globulins in different models of inflammation in rats.
Topics: Acute Disease; Adjuvants, Immunologic; Animals; Arthritis; Aspirin; Disease Models, Animal; Granulom | 1971 |
Chemical prevention of experimental allergic encephalomyelitis in rats: a quantitative evaluation of steroids and various non-steroid drugs.
Topics: Aminopyrine; Animals; Anti-Inflammatory Agents; Bis-Trimethylammonium Compounds; Cortisone; Cyclopho | 1971 |
The treatment of acute lymphocytic leukemia.
Topics: Animals; Antineoplastic Agents; Asparaginase; Blood Platelets; Bone Marrow Cells; Cyclophosphamide; | 1970 |
The effect of cortisone on the development of Schistosoma haematobium in mice.
Topics: Animals; Disease Models, Animal; Mice; Mice, Inbred Strains; Prednisone; Schistosoma haematobium; Sc | 1969 |
Cryotherapy of stromal herpes simplex keratitis in rabbits.
Topics: Animals; Cataract; Cornea; Cryosurgery; Disease Models, Animal; Keratitis, Dendritic; Prednisone; Pr | 1971 |